RxDoctor Payments Data

Shilpa Gupta

Pediatric Endocrinology · Riverside, CANPI 1659588754

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by EMD Serono, Inc. at 57.5% of the total. Reporting peaked in 2023 at $2,505 and has fallen 85.2% since, to $370 in 2025.

$3,602in general payments, 2019–2025

Across 82 payments — averaging $43.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$2K
  • Ascendis Pharma Endocrinology Inc$288
  • Tolmar, Inc.$240
  • Tolmar Pharmaceuticals, Inc.$196
  • Novartis$135
  • AbbVie$91
  • plus $580 from 17 others

What the payments were for

  • Consulting fees$2,07057%
  • Food & beverage$1,36538%
  • Education$1675%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,602 in reported general payments places this provider in the 70th percentile of 168 pediatric endocrinology providers in California.

See all pediatric endocrinology providers in California →

Other pediatric endocrinology in Riverside

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →